China will adjust tariffs on imported U.S. products from 12:01 p.m. Wednesday, the Customs Tariff Commission of the State Council announced on Tuesday.

The immunoassay segment accounts about 35% of the market, with no growth compared to the previous year. Domestic brands account for over 35%.

Runda Medical issued a performance forecast, and it is expected that the net profit attributable to shareholders of listed companies will be between 195 million yuan and 215 million yuan in the first half of 2021, an increase of 75.33% year-on-year to 93.31%.

Recently, Fosun Pharma announced that the approval of the mRNA novel coronal vaccine by the Food and Drug Administration has been basically completed, and the expert review has passed. The administrative approval stage is being stepped up at present.

On July 14, China Securities Regulatory Commission (CSRC) released the news and approved the IPO registration of Sino Biological, Inc. Sino Biological is an international reagent supplier and service provider, which specializes in recombinant protein production and antibody development.

Medix Biochemica, a global leader in critical IVD raw materials, has acquired all of the shares of Diaclone SAS ("Diaclone"). Through acquisition, Medix Biochemica broadens its portfolio of critical raw materials for the in-vitro diagnostics ("IVD") industry and expands its global network.

Today, WHO and HRP have launched a new guideline to help countries make faster progress, more equitably, on the screening and treatment of this devastating disease.

On July 9th, Roche Diagnostics Asia-Pacific production base and R&D center built another new manufacturing building-System Reagent Manufacturing Base. It was officially completed in Suzhou Industrial Park. The total investment in the project is 390 million yuan.

Recently, it was learned from Shanghai Fosun Pharma officially signed a sales agreement with TSMC, FOXCONN, YongLin, and Zuellig Pharma, respectively, to sell a total of 10 million doses of COVID-mRNA vaccine. This batch of vaccine will be donated to local vaccination in Taiwan.

On July 6, 2021, Agilent Technologies (NYSE: A) announced a strategic collaboration with GenomiCare Biotechnology in a move aimed to advance the application of the latest Next Generation Sequencing (NGS) technology into the clinical and scientific arena.

Quidel has issued a recall for certain lots of its Lyra brand SARS-CoV-2 tests due to the potential for false negative results in patient samples with relatively high amounts of virus.

Global life sciences leader Cytiva has acquired Intermountain Life Sciences, a manufacturer of high-purity water, buffers, and liquid cell culture media. Cytiva will use Intermountain’s manufacturing site in Utah to rapidly boost its liquid cell culture production by millions of liters.